We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$25.3M
Cap. Flow
+$32.9M
Cap. Flow %
8.36%
Top 10 Hldgs %
80.79%
Holding
223
New
14
Increased
85
Reduced
52
Closed
29

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$10.8M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$10.2M
3
MCRB icon
Seres Therapeutics
MCRB
+$1.62M
4
VUZI icon
Vuzix
VUZI
+$1.34M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.16M

Top Sells

Rank Stock Value
1
OUST icon
Ouster
OUST
+$1.06M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.02M
3
TVTX icon
Travere Therapeutics
TVTX
+$897K
4
ADCT icon
ADC Therapeutics
ADCT
+$633K
5
RBOT
Vicarious Surgical
RBOT
+$548K

Sector Composition

Rank Sector Weight
1 Real Estate 18.05%
2 Healthcare 12.08%
3 Technology 1.59%
4 Financials 1.03%
5 Industrials 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBB icon
1
iShares MBS ETF
MBB
$39.3B
$142M 36%
1,310,000
+100,000
+8% +$10.8M
VMBS icon
2
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
$101M 25.66%
1,895,000
+190,000
+11% +$10.2M
INVH icon
3
Invitation Homes
INVH
$17.9B
$32.7M 8.32%
854,144
– –
AMH icon
4
American Homes 4 Rent
AMH
$12.3B
$30.8M 7.82%
806,924
– –
RITM icon
5
Rithm Capital
RITM
$5.2B
$2.7M 0.69%
245,158
– –
SHY icon
6
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$2.04M 0.52%
23,625
+8,565
+57% +$738K
STXS icon
7
Stereotaxis
STXS
$154M
$1.88M 0.48%
350,000
+25,000
+8% +$188K
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$123B
$1.86M 0.47%
10,250
+3,000
+41% +$586K
ISRG icon
9
Intuitive Surgical
ISRG
$122B
$1.74M 0.44%
5,250
-750
-13% -$252K
LKFT
10
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.97B
$1.55M 0.39%
29,500
+8,000
+37% +$475K
AZTA icon
11
Azenta
AZTA
$1.21B
$1.53M 0.39%
15,000
– –
SNPS icon
12
Synopsys
SNPS
$73.6B
$1.5M 0.38%
5,000
-500
-9% -$152K
OMCL icon
13
Omnicell
OMCL
$2.09B
$1.48M 0.38%
10,000
– –
AVAV icon
14
AeroVironment
AVAV
$7.2B
$1.29M 0.33%
15,000
– –
AME icon
15
Ametek
AME
$54.3B
$1.24M 0.32%
10,000
– –
ACAD icon
16
Acadia Pharmaceuticals
ACAD
$4.38B
$1.22M 0.31%
73,500
+60,000
+444% +$1.16M
MOR
17
DELISTED
MorphoSys AG American Depositary Shares
MOR
$1.19M 0.3%
101,000
+55,500
+122% +$804K
ALNT icon
18
Allient
ALNT
$1.49B
$1.17M 0.3%
37,500
– –
OYST
19
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$1.17M 0.3%
98,500
+62,000
+170% +$903K
NOVT icon
20
Novanta
NOVT
$5.3B
$1.16M 0.29%
7,500
– –
MCRB icon
21
Seres Therapeutics
MCRB
$51.6M
$1.15M 0.29%
+8,275
New +$1.62M
COGT icon
22
Cogent Biosciences
COGT
$6.68B
$1.13M 0.29%
134,475
+11,975
+10% +$91.8K
EFC
23
Ellington Financial
EFC
$1.7B
$1.1M 0.28%
60,283
+28,283
+88% +$519K
BTAI icon
24
BioXcel Therapeutics
BTAI
$27.4M
$1.06M 0.27%
2,188
+625
+40% +$275K
INCY icon
25
Incyte
INCY
$23.4B
$1.05M 0.27%
15,250
+11,250
+281% +$855K
1
2 3 4 5

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, AlphaCentric Advisors held 223 positions worth $393M, up 6.9% from $368M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

AlphaCentric Advisors deployed $32.9M of net new capital in Q3 2021, opening 14 new positions and adding to 85 existing holdings. Its largest new stake was Seres Therapeutics: 8,275 shares worth $1.15M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $1.02M trimmed.

  • AlphaCentric Advisors's largest Q3 2021 buy was Seres Therapeutics: 8,275 shares worth $1.15M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q3 2021, an estimated $10.8M increase.
  • AlphaCentric Advisors's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.02M.
  • AlphaCentric Advisors fully exited Ouster in Q3 2021, selling an estimated $1.06M.
  • AlphaCentric Advisors's ten largest holdings make up 81% of its $393M portfolio in Q3 2021.
  • AlphaCentric Advisors opened 14 new positions and closed 29 in Q3 2021.
  • AlphaCentric Advisors's portfolio value rose 6.9% quarter-over-quarter to $393M.

Based on AlphaCentric Advisors's 13F filing for Q3 2021, filed 9 Mar 2022.